Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes.
about
Acacetin inhibits expression of matrix metalloproteinases via a MAPK-dependent mechanism in fibroblast-like synoviocytesAnti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models.Taurine and inflammatory diseases.Taurine chloramine produced from taurine under inflammation provides anti-inflammatory and cytoprotective effects.Taurine chloramine induces apoptosis in human osteosarcoma cell lines.Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more thanEffect of taurine chloramine on the production of matrix metalloproteinases (MMPs) in adiponectin- or IL-1beta-stimulated fibroblast-like synoviocytes.WIN-34B May Have Analgesic and Anti-Inflammatory Effects by Reducing the Production of Pro-Inflammatory Mediators in Cells via Inhibition of IκB Signaling PathwaysSynergy between adiponectin and interleukin-1β on the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in fibroblast-like synoviocytes.Anti-obesity and hypolipidaemic effects of Nelumbo nucifera seed ethanol extract in human pre-adipocytes and rats fed a high-fat diet.Taurine chloramine modulates the expression of adipokines through inhibition of the STAT-3 signaling pathway in differentiated human adipocytes.Effect of inhibiting MMP13 and ADAMTS5 by intra-articular injection of small interfering RNA in a surgically induced osteoarthritis model of mice.Effects and Mechanisms of Taurine as a Therapeutic Agent.Increased expression of IL-1 receptors in response to IL-1β may produce more IL-6, IL-8, VEGF, and PGE₂ in senescent synovial cells induced in vitro than in presenescent cells.
P2860
Q35995090-A084AB1C-FDFF-4469-91FA-E69CC8E47222Q37206957-4EB6C5C3-4462-468E-97DF-E8838A7D7887Q38027405-EA6B6089-8E4D-499E-8F9F-33303033B670Q38128187-87D13ACB-9284-4AE8-842B-DF3F37B01DB7Q39335698-007B08D6-5BDF-4B7B-AC8A-63D1A1728724Q41201384-1C6B32E7-F69A-41E7-A28E-520CE0056D7EQ41392263-44B38A71-F543-4B19-8CEF-3F28F98FBAE7Q42182748-227E6C39-3430-4707-AC4D-C28D67AC6964Q42251912-07E8F1FF-275A-4501-8464-5FE91B4784DEQ42817080-B76811CD-9D38-49EF-8129-44D474178508Q43653589-E9871C81-F7D7-4ACC-9A57-9FB994AB2485Q51170274-9DC1FCF0-31E2-4B49-A9F8-D0B56A413BD4Q52598336-918F4F98-CC13-4BCF-A405-33C23EE6F147Q53256016-B3E4733A-0CF6-4AD0-81C2-F2190225A2E3
P2860
Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Taurine chloramine differentia ...... fibroblast-like synoviocytes.
@en
Taurine chloramine differentia ...... fibroblast-like synoviocytes.
@nl
type
label
Taurine chloramine differentia ...... fibroblast-like synoviocytes.
@en
Taurine chloramine differentia ...... fibroblast-like synoviocytes.
@nl
prefLabel
Taurine chloramine differentia ...... fibroblast-like synoviocytes.
@en
Taurine chloramine differentia ...... fibroblast-like synoviocytes.
@nl
P2093
P2860
P356
P1476
Taurine chloramine differentia ...... fibroblast-like synoviocytes.
@en
P2093
Chaekyun Kim
Eun Kyung Park
Hye-Sook Jung
Hyung-In Yang
Jun Soo Bang
Kyoung Soo Kim
Myung Chul Yoo
Sang-Hoon Lee
Seung Min Ju
Seung-Jae Hong
P2860
P2888
P356
10.1186/AR2279
P577
2007-01-01T00:00:00Z
P5875
P6179
1015359076